COVID-19-Induced Hyperleucocytosis in Chronic Lymphocytic Leukaemia | Zendy

Balraj Singh | Zendy; Sarah Ayad | Zendy; Parminder Kaur | Zendy; Ro-Jay Reid | Zendy; Sachin Gupta | Zendy; Michael Maroules | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

COVID-19-Induced Hyperleucocytosis in Chronic Lymphocytic Leukaemia

Author(s) -

Balraj Singh,

Sarah Ayad,

Parminder Kaur,

Ro-Jay Reid,

Sachin Gupta,

Michael Maroules

Publication year - 2021

Publication title -

european journal of case reports in internal medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.125

H-Index - 1

ISSN - 2284-2594

DOI - 10.12890/2021_002348

Subject(s) - medicine , covid-19 , pandemic , coronavirus , respiratory system , disease , immunology , virology , infectious disease (medical specialty) , outbreak

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus responsible for the current global pandemic, coronavirus disease 2019 (COVID-19). COVID-19 usually presents with respiratory symptoms but can affect multiple organ systems. A wide spectrum of complications can occur depending upon the comorbidities of patients. There is limited literature available regarding the presentation and outcome of COVID-19 in chronic lymphocytic leukaemia (CLL) patients. We report 2 cases of COVID-19-induced hyperleucocytosis (WBC count >100,000/?l) in CLL patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research